Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Press Joseph | 0001903092 | Sep-27-2021 | director |
Pilo Shlomo | 0001903730 | Sep-27-2021 | director, 10 percent owner, officer: Chief Executive Officer |
Louria Hayon Igal | 0001903781 | Sep-27-2021 | director, officer: Chief Technology Officer |
Eliya Yehuda | 0001904163 | Sep-27-2021 | director |
CATELL ROBERT B | 0001195325 | Sep-30-2010 | director |
Yanay Elisha | 0001402863 | Sep-30-2010 | director |
SHAMASH YACOV A | 0001013589 | Jul-23-2010 | director |
Ofir Guy | 0001424145 | Dec-18-2007 | director, 10 percent owner, officer: President |
Cohen Emanuel | 0001424146 | Dec-18-2007 | director, 10 percent owner, officer: Secretary Treasurer Director |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Raphael Pharmaceutical Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-24-027234 (34 Act) Size: 4409 KB |
Mar-28-2024 | 24799161 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-025520 ( Act) Size: 4 KB |
Mar-25-2024 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-24-025519 ( Act) Size: 6 KB |
Mar-25-2024 | |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-086894 (34 Act) Size: 1357 KB |
Nov-14-2023 | 231405651 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-065005 (34 Act) Size: 1278 KB |
Aug-09-2023 | 231154977 |
EFFECT | Document | Acc-no: 9999999995-23-001732 (33 Act) Size: 1 KB | Jun-13-2023 | 231012876 |
EFFECT | Document | Acc-no: 9999999995-23-001729 (33 Act) Size: 1 KB | Jun-13-2023 | 231012872 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001213900-23-044792 (33 Act) Size: 5425 KB |
Jun-01-2023 | 23983639 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001213900-23-044791 (33 Act) Size: 5424 KB |
Jun-01-2023 | 23983635 |
10-K/A | Document | Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-23-043104 (34 Act) Size: 3144 KB |
May-25-2023 | 23961231 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001213900-23-039833 (34 Act) Size: 1289 KB |
May-15-2023 | 23923105 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001213900-23-036405 (33 Act) Size: 4057 KB |
May-04-2023 | 23888480 |
POS AM | Document | Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001213900-23-035523 (33 Act) Size: 4091 KB |
May-02-2023 | 23878783 |
8-K | Document | Current report filing Acc-no: 0001213900-23-023667 (34 Act) Size: 186 KB |
Mar-28-2023 | 23769401 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001213900-23-022628 (34 Act) Size: 3862 KB |
Mar-24-2023 | 23757898 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-23-019558 ( Act) Size: 5 KB |
Mar-13-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-23-019557 ( Act) Size: 5 KB |
Mar-13-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-23-019556 ( Act) Size: 6 KB |
Mar-13-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-23-019554 ( Act) Size: 5 KB |
Mar-13-2023 | |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001213900-23-019553 ( Act) Size: 6 KB |
Mar-13-2023 |
Recent 20 filings. View all Raphael Pharmaceutical Inc. filings
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by